Stockscreener 앱 받기
7.24
2.69%
-0.20
시간 외 거래:
7.11
-0.13
-1.80%
전일 마감가:
$7.44
열려 있는:
$7.49
하루 거래량:
1.18M
Relative Volume:
0.78
시가총액:
$741.61M
수익:
$187.64M
순이익/손실:
$-95.00M
주가수익비율:
-7.6211
EPS:
-0.95
순현금흐름:
$-69.02M
1주 성능:
-8.93%
1개월 성능:
-0.28%
6개월 성능:
+7.10%
1년 성능:
-46.49%
1일 변동 폭
$7.23
$7.51
1주일 범위
$7.135
$8.01
52주 변동 폭
$5.635
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
명칭
Day One Biopharmaceuticals Inc
전화
650 484-0899
주소
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
DAWN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
7.24 | 762.09M | 187.64M | -95.00M | -69.02M | -0.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2024-10-09 | 재확인 | Needham | Buy |
| 2024-08-01 | 업그레이드 | BofA Securities | Underperform → Buy |
| 2024-04-24 | 재확인 | Needham | Buy |
| 2023-04-25 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-02-08 | 개시 | CapitalOne | Overweight |
| 2023-02-03 | 개시 | Oppenheimer | Perform |
| 2022-12-15 | 개시 | H.C. Wainwright | Buy |
| 2022-12-14 | 개시 | Needham | Buy |
| 2022-12-05 | 개시 | Goldman | Buy |
| 2022-12-01 | 개시 | BofA Securities | Buy |
모두보기
Day One Biopharmaceuticals Inc 주식(DAWN)의 최신 뉴스
Signal strength of Day One Biopharmaceuticals Inc. stock in tech scannersJuly 2025 Price Swings & Reliable Breakout Forecasts - newser.com
How to recover losses in Day One Biopharmaceuticals Inc. stockJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - newser.com
Published on: 2025-10-10 04:42:27 - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Day One Biopharmaceuticals (NASDAQ:DAWN) - MarketBeat
Is Day One Biopharmaceuticals Inc. stock oversold or undervaluedJuly 2025 News Drivers & Risk Managed Investment Strategies - newser.com
Published on: 2025-10-09 05:35:06 - newser.com
Day One Biopharmaceuticals Hits Day Low of $7.27 Amid Price Pressure - Markets Mojo
Day One Biopharmaceuticals (DAWN) Moves 7.0% Higher: Will This Strength Last? - Nasdaq
How to read the order book for Day One Biopharmaceuticals Inc.2025 Analyst Calls & Consistent Profit Trade Alerts - newser.com
Smart tools for monitoring Day One Biopharmaceuticals Inc.’s price actionStock Surge & AI Forecasted Entry/Exit Points - newser.com
Can volume confirm reversal in Day One Biopharmaceuticals Inc.Trade Volume Summary & Growth Focused Stock Reports - newser.com
Day One Biopharmaceuticals Experiences Evaluation Revision Amidst Market Challenges and Mixed Performance Indicators - Markets Mojo
Live market analysis of Day One Biopharmaceuticals Inc.2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
What makes Day One Biopharmaceuticals Inc. stock attractive to growth fundsWeekly Market Outlook & Low Risk High Win Rate Stock Picks - newser.com
What analysts say about Day One Biopharmaceuticals Inc stockSupport Zone Identification & High Profit Market Ideas - earlytimes.in
What drives Day One Biopharmaceuticals Inc stock priceMarket Sentiment Shifts & Maximize ROI With Proven Growth Stocks - earlytimes.in
H.C. Wainwright Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating, Maintains Target Price $25 - 富途牛牛
H.C. Wainwright reiterates Buy rating on Day One Biopharmaceuticals stock By Investing.com - Investing.com Canada
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of "Buy" by Analysts - MarketBeat
Institutional scanner results for Day One Biopharmaceuticals Inc.July 2025 Opening Moves & AI Optimized Trade Strategies - newser.com
Rhumbline Advisers Boosts Stock Position in Day One Biopharmaceuticals, Inc. $DAWN - Defense World
Day One Biopharmaceuticals Inc (DAWN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Day One Biopharmaceuticals Inc 주식 (DAWN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Dubow Adam | Gen Counsel & Secretary |
Aug 18 '25 |
Sale |
6.77 |
4,365 |
29,538 |
54,858 |
| Bender Jeremy | CHIEF EXECUTIVE OFFICER |
Aug 18 '25 |
Sale |
6.77 |
16,058 |
108,666 |
161,365 |
| Merendino Lauren | Chief Commercial Officer |
Aug 18 '25 |
Sale |
6.77 |
3,766 |
25,485 |
41,931 |
5.74%
자본화:
|
볼륨(24시간):